Bristol-Myers Squibb Company (BMY) Partners Again With Ambrx, Inc. in Up to $112 Million and Up ADC Collaboration
5/3/2013 7:19:51 AM
More...
|
Astellas Pharma Inc. (YPH.BE) Signs $300 Million Cancer Pact With Ambrx, Inc.
4/5/2013 7:49:05 AM
More...
|
Ambrx, Inc. Appoints Lawson Macartney, Ph.D., DVM, CEO
1/7/2013 6:48:52 AM
More...
|
Merck & Co., Inc. (MRK) Bets Up to $303 Million on Ambrx, Inc.'s "Smart Bomb" Antibodies
6/18/2012 6:38:52 AM
More...
|
Bristol-Myers Squibb Company (BMY) and Ambrx, Inc. Announce $24 Million Collaboration for Novel Biologics Programs in Diabetes and Heart Failure
9/22/2011 6:54:12 AM
More...
|
Ambrx, Inc. to Present Data from Antibody Drug Conjugate Program at Upcoming Scientific Conferences
6/22/2011 8:53:42 AM
More...
|
Proceedings of the National Academy of Sciences Report Superiority of Human Growth Hormone Generated with Ambrx, Inc.
5/25/2011 10:33:25 AM
More...
|
Ambrx, Inc. CEO Steve Kaldor Departs
7/13/2010 8:02:07 AM
More...
|
Wyeth (WYE) (JOBS) and Ambrx, Inc. (JOBS) Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
9/18/2009 6:38:32 AM
More...
|
Ambrx, Inc. Raises $10 Million
4/1/2009 7:44:54 AM
More...
|
|